(AP5) AP5 supports the overall mission of this ICBG - discovering and developing therapeutic agents to treat invasive fungal infections and cancer - in several ways: dereplicating active compounds from bacterial extracts, discovering metabolites identified by genome mining, providing follow-up chemistry, housing the anticancer therapeutic discovery pipeline, administering overall group activities, and assisting in the development of both scientific personnel and research infrastructure in Brazil. These activities are embodied in four specific aims described below. 1. Identify and supply active molecules and derivatives to the antifungal and anticancer screening platforms. AP5 will speed up this traditional bottleneck by waiting for potency/selectivity data before beginning dereplicaton, using NMR techniques on partially purified fractions, and trying an new approach to high- throughput crystallography. 2. AP5 will also carry out studies to identify cryptic metabolites - molecules whose biosynthetic genes can be identified but that have never been characterized. AP5 will use two approaches: elicitor/co-culture stimulation and genetic knockouts coupled with differential metabolomics. 3. A high-throughput anticancer drug discovery pipeline that runs from primary assays to in vivo studies will be used to identify small molecules with therapeutic potential for blood cancers. These assays utilize 24 cell lines from 6 types of blood cancer, and all cell lines have been genomically characterized so that initial phenotypic screening results can reveal something about mechanism. 4. AP5 will also carry out many of the administrative functions: research agreements, database, communications, and training.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19TW009872-01
Application #
8785547
Study Section
Special Emphasis Panel (ZRG1-BCMB-H (50))
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$23,301
Indirect Cost
$8,687
Name
Harvard Medical School
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Van Arnam, Ethan B; Currie, Cameron R; Clardy, Jon (2018) Defense contracts: molecular protection in insect-microbe symbioses. Chem Soc Rev 47:1638-1651
Silva-Junior, Eduardo A; Ruzzini, Antonio C; Paludo, Camila R et al. (2018) Pyrazines from bacteria and ants: convergent chemistry within an ecological niche. Sci Rep 8:2595
Li, Hongjie; Sosa-Calvo, Jeffrey; Horn, Heidi A et al. (2018) Convergent evolution of complex structures for ant-bacterial defensive symbiosis in fungus-farming ants. Proc Natl Acad Sci U S A 115:10720-10725
Paludo, Camila R; Menezes, Cristiano; Silva-Junior, Eduardo A et al. (2018) Stingless Bee Larvae Require Fungal Steroid to Pupate. Sci Rep 8:1122
Ortega, Humberto E; Batista Jr, João M; Melo, Weilan G P et al. (2017) Absolute Configurations of Griseorhodins A and C. Tetrahedron Lett 58:4721-4723
Ramadhar, Timothy R; Zheng, Shao-Liang; Chen, Yu-Sheng et al. (2017) The Crystalline Sponge Method: A Solvent-Based Strategy to Facilitate Noncovalent Ordered Trapping of Solid and Liquid Organic Compounds. CrystEngComm 19:4528-4534
Gemperline, Erin; Horn, Heidi A; DeLaney, Kellen et al. (2017) Imaging with Mass Spectrometry of Bacteria on the Exoskeleton of Fungus-Growing Ants. ACS Chem Biol 12:1980-1985
Wyche, Thomas P; Ruzzini, Antonio C; Schwab, Laura et al. (2017) Tryptorubin A: A Polycyclic Peptide from a Fungus-Derived Streptomycete. J Am Chem Soc 139:12899-12902
Adnani, Navid; Rajski, Scott R; Bugni, Tim S (2017) Symbiosis-inspired approaches to antibiotic discovery. Nat Prod Rep 34:784-814
Lewin, Gina R; Carlos, Camila; Chevrette, Marc G et al. (2016) Evolution and Ecology of Actinobacteria and Their Bioenergy Applications. Annu Rev Microbiol 70:235-54

Showing the most recent 10 out of 17 publications